579 related articles for article (PubMed ID: 30635059)
21. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine.
Lange C; Cakiroglu F; Spiess AN; Cappallo-Obermann H; Dierlamm J; Zander AR
J Cell Physiol; 2007 Oct; 213(1):18-26. PubMed ID: 17458897
[TBL] [Abstract][Full Text] [Related]
22. Defined Essential 8™ Medium and Vitronectin Efficiently Support Scalable Xeno-Free Expansion of Human Induced Pluripotent Stem Cells in Stirred Microcarrier Culture Systems.
Badenes SM; Fernandes TG; Cordeiro CS; Boucher S; Kuninger D; Vemuri MC; Diogo MM; Cabral JM
PLoS One; 2016; 11(3):e0151264. PubMed ID: 26999816
[TBL] [Abstract][Full Text] [Related]
23. Xeno-free protocol for GMP-compliant manufacturing of human fetal pancreas-derived mesenchymal stem cells.
Jabbarpour Z; Aghayan S; Arjmand B; Fallahzadeh K; Alavi-Moghadam S; Larijani B; Aghayan HR
Stem Cell Res Ther; 2022 Jun; 13(1):268. PubMed ID: 35729640
[TBL] [Abstract][Full Text] [Related]
24. Development of a Xeno-Free Feeder-Layer System from Human Umbilical Cord Mesenchymal Stem Cells for Prolonged Expansion of Human Induced Pluripotent Stem Cells in Culture.
Zou Q; Wu M; Zhong L; Fan Z; Zhang B; Chen Q; Ma F
PLoS One; 2016; 11(2):e0149023. PubMed ID: 26882313
[TBL] [Abstract][Full Text] [Related]
25. Robust production of human neural cells by establishing neuroepithelial-like stem cells from peripheral blood mononuclear cell-derived feeder-free iPSCs under xeno-free conditions.
Isoda M; Kohyama J; Iwanami A; Sanosaka T; Sugai K; Yamaguchi R; Matsumoto T; Nakamura M; Okano H
Neurosci Res; 2016 Sep; 110():18-28. PubMed ID: 27083781
[TBL] [Abstract][Full Text] [Related]
26. Xeno-Free Cultivation of Mesenchymal Stem Cells From the Corneal Stroma.
Matthyssen S; Ní Dhubhghaill S; Van Gerwen V; Zakaria N
Invest Ophthalmol Vis Sci; 2017 May; 58(5):2659-2665. PubMed ID: 28524929
[TBL] [Abstract][Full Text] [Related]
27. Pooled human serum: A new culture supplement for bioreactor-based cell therapies. Preliminary results.
Savelli S; Trombi L; D'Alessandro D; Moscato S; Pacini S; Giannotti S; Lapi S; Scatena F; Petrini M
Cytotherapy; 2018 Apr; 20(4):556-563. PubMed ID: 29429942
[TBL] [Abstract][Full Text] [Related]
28. Human adipose tissue-derived stem cells cultured in xeno-free culture condition enhance c-MYC expression increasing proliferation but bypassing spontaneous cell transformation.
Paula AC; Martins TM; Zonari A; Frade SP; Angelo PC; Gomes DA; Goes AM
Stem Cell Res Ther; 2015 Apr; 6(1):76. PubMed ID: 25889298
[TBL] [Abstract][Full Text] [Related]
29. Characterization and Therapeutic Application of Mesenchymal Stem Cells with Neuromesodermal Origin from Human Pluripotent Stem Cells.
Wang H; Li D; Zhai Z; Zhang X; Huang W; Chen X; Huang L; Liu H; Sun J; Zou Z; Fan Y; Ke Q; Lai X; Wang T; Li X; Shen H; Xiang AP; Li W
Theranostics; 2019; 9(6):1683-1697. PubMed ID: 31037131
[No Abstract] [Full Text] [Related]
30. Regulation of Immune Checkpoint Antigen CD276 (B7-H3) on Human Placenta-Derived Mesenchymal Stromal Cells in GMP-Compliant Cell Culture Media.
Amend B; Buttgereit L; Abruzzese T; Harland N; Abele H; Jakubowski P; Stenzl A; Gorodetsky R; Aicher WK
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003612
[TBL] [Abstract][Full Text] [Related]
31. Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions.
Santos Fd; Andrade PZ; Abecasis MM; Gimble JM; Chase LG; Campbell AM; Boucher S; Vemuri MC; Silva CL; Cabral JM
Tissue Eng Part C Methods; 2011 Dec; 17(12):1201-10. PubMed ID: 21895491
[TBL] [Abstract][Full Text] [Related]
32. Optimization of culture conditions for the expansion of umbilical cord-derived mesenchymal stem or stromal cell-like cells using xeno-free culture conditions.
Hatlapatka T; Moretti P; Lavrentieva A; Hass R; Marquardt N; Jacobs R; Kasper C
Tissue Eng Part C Methods; 2011 Apr; 17(4):485-93. PubMed ID: 21166520
[TBL] [Abstract][Full Text] [Related]
33. Mesenchymal Stem Cells Obtained from Synovial Fluid Mesenchymal Stem Cell-Derived Induced Pluripotent Stem Cells on a Matrigel Coating Exhibited Enhanced Proliferation and Differentiation Potential.
Zheng YL; Sun YP; Zhang H; Liu WJ; Jiang R; Li WY; Zheng YH; Zhang ZG
PLoS One; 2015; 10(12):e0144226. PubMed ID: 26649753
[TBL] [Abstract][Full Text] [Related]
34. A Newly Defined and Xeno-Free Culture Medium Supports Every-Other-Day Medium Replacement in the Generation and Long-Term Cultivation of Human Pluripotent Stem Cells.
Ahmadian Baghbaderani B; Tian X; Scotty Cadet J; Shah K; Walde A; Tran H; Kovarcik DP; Clarke D; Fellner T
PLoS One; 2016; 11(9):e0161229. PubMed ID: 27606941
[TBL] [Abstract][Full Text] [Related]
35. Culture of human mesenchymal stem cells using a candidate pharmaceutical grade xeno-free cell culture supplement derived from industrial human plasma pools.
Díez JM; Bauman E; Gajardo R; Jorquera JI
Stem Cell Res Ther; 2015 Mar; 6(1):28. PubMed ID: 25889980
[TBL] [Abstract][Full Text] [Related]
36. Induction of pluripotent stem cells by reprogramming human ocular fibroblasts under xeno-free conditions.
Xiong Y; Liu Y; Ge J
Arq Bras Oftalmol; 2018; 81(5):376-383. PubMed ID: 30208139
[TBL] [Abstract][Full Text] [Related]
37. Effect of allogeneic platelet lysate on equine bone marrow derived mesenchymal stem cell characteristics, including immunogenic and immunomodulatory gene expression profile.
Yaneselli K; Barrachina L; Remacha AR; Algorta A; Vitoria A; Cequier A; Romero A; Vázquez FJ; Maisonnave J; Rodellar C
Vet Immunol Immunopathol; 2019 Nov; 217():109944. PubMed ID: 31563725
[TBL] [Abstract][Full Text] [Related]
38. Comparison of clinical grade human platelet lysates for cultivation of mesenchymal stromal cells from bone marrow and adipose tissue.
Juhl M; Tratwal J; Follin B; Søndergaard RH; Kirchhoff M; Ekblond A; Kastrup J; Haack-Sørensen M
Scand J Clin Lab Invest; 2016; 76(2):93-104. PubMed ID: 26878874
[TBL] [Abstract][Full Text] [Related]
39. Synergistic effect of medium, matrix, and exogenous factors on the adhesion and growth of human pluripotent stem cells under defined, xeno-free conditions.
Meng G; Liu S; Rancourt DE
Stem Cells Dev; 2012 Jul; 21(11):2036-48. PubMed ID: 22149941
[TBL] [Abstract][Full Text] [Related]
40. Fibroblast growth factor improves the motility of human mesenchymal stem cells expanded in a human plasma-derived xeno-free medium through αVβ3 integrin.
Blázquez-Prunera A; Almeida CR; Barbosa MA
J Tissue Eng Regen Med; 2019 Jan; 13(1):36-45. PubMed ID: 30362664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
